305 related articles for article (PubMed ID: 23849582)
41. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
[TBL] [Abstract][Full Text] [Related]
42. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
[TBL] [Abstract][Full Text] [Related]
43. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
44. Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.
van Leeuwen PJ; van den Bergh RC; Wolters T; Zhu X; Bul M; Schröder FH; Bangma CH; Roobol MJ
Can J Urol; 2011 Dec; 18(6):6018-24. PubMed ID: 22166329
[TBL] [Abstract][Full Text] [Related]
45. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
46. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
47. Screening for prostate cancer.
Pode D; Shapiro A; Lebensart P; Meretyk S; Katz G; Barak V
Isr J Med Sci; 1995; 31(2-3):125-8. PubMed ID: 7538101
[TBL] [Abstract][Full Text] [Related]
48. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
[TBL] [Abstract][Full Text] [Related]
49. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
Issa MM; Zasada W; Ward K; Hall JA; Petros JA; Ritenour CW; Goodman M; Kleinbaum D; Mandel J; Marshall FF
Cancer Detect Prev; 2006; 30(3):269-75. PubMed ID: 16844319
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
[TBL] [Abstract][Full Text] [Related]
51. Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
Mori RR; Faria EF; Mauad EC; Rodrigues AA; Dos Reis RB
Int Braz J Urol; 2020; 46(1):34-41. PubMed ID: 31851456
[TBL] [Abstract][Full Text] [Related]
52. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
[TBL] [Abstract][Full Text] [Related]
53. A comparative analysis of prostate cancer pre-treatment characteristics stratified by age.
Shah N; Ioffe V; Kapur A
Can J Urol; 2014 Apr; 21(2):7213-6. PubMed ID: 24775574
[TBL] [Abstract][Full Text] [Related]
54. Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective.
Kash DP; Lal M; Hashmi AH; Mubarak M
Asian Pac J Cancer Prev; 2014; 15(7):3087-91. PubMed ID: 24815452
[TBL] [Abstract][Full Text] [Related]
55. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
[TBL] [Abstract][Full Text] [Related]
56. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
[TBL] [Abstract][Full Text] [Related]
57. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran.
Safarinejad MR
Ann Oncol; 2006 Jul; 17(7):1166-71. PubMed ID: 16684791
[TBL] [Abstract][Full Text] [Related]
58. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
Tourville EA; Nguyen MM
Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
[TBL] [Abstract][Full Text] [Related]
59. [The significance of early detection for prostate cancer in mass screening].
Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
[TBL] [Abstract][Full Text] [Related]
60. Prostate biopsy findings in Indian men: a hospital-based study.
Sinha S; Siriguri SR; Kanakmedala SK; Bikkasani K
Indian J Cancer; 2011; 48(2):175-80. PubMed ID: 21768662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
